Related references
Note: Only part of the references are listed.Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
Wiebren A. Tjalma et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
Debbie Saslow et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study
Francesca Carozzi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial
Edith Roset Bahmanyar et al.
GYNECOLOGIC ONCOLOGY (2012)
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen et al.
LANCET ONCOLOGY (2012)
Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys
Salvatore Vaccarella et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Estimating Progression Rates for Human Papillomavirus Infection From Epidemiological Data
Mark Jit et al.
MEDICAL DECISION MAKING (2010)
Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States
Cosette M. Wheeler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS
Anil K. Chaturvedi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis
Jill Koshiol et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen et al.
LANCET (2007)
Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR
Leen-Jan van Doorn et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse
NWJ Bulkmans et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines
F Méndez et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The carcinogenicity of human papillornavirus types reflects viral evolution
M Schiffman et al.
VIROLOGY (2005)
Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated
SJ Weissenborn et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students
RL Winer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
JS Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection
MC Rousseau et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types
KL Liaw et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
